You can join more than 18,000 people who have filed product liability lawsuits against Bayer, owner of Monsanto’s Roundup herbicide after they were diagnosed with cancer from exposure to the weed killer.
CRITERIA FOR FILING A LAWSUIT FOR YOUR ROUNDUP-CAUSED CANCER
When you file a Roundup weed killer cancer lawsuit—or any products liability claim—against a manufacturer, distributor, or seller of a product that has caused you harm, your burden as the plaintiff, is to prove the following:
- The defendant sells a product that you used.
- The defendant sells the product commercially.
- You sustained an injury from using the defendant’s product.
- The product was defective when the defendant sold it.
- Your injury resulted from the defect in the defendant’s product.
HOW YOU WILL PROVE YOUR CASE
You will need to prove that you used or were exposed to the herbicide and provide medical proof that you have been diagnosed with cancer.
The legal team at Zanes Law will do everything from A to Z, from gathering this type of evidence to build your case to handling every aspect of your case, so you can focus on your recovery. Call us today for a free case review: (833) 214-0917.
HOW THE REMAINING ELEMENTS OF YOUR CASE WILL BE PROVED
With regard to the idea that Roundup to which you were exposed was defective when it was sold and that your cancer was caused by the weed killer, the pieces of evidence to support these arguments are presented in the discovery and pretrial proceedings of the multidistrict litigation case (MDL No. 2741) where all pending products liability cases against Monsanto have been consolidated for the purpose of sharing such procedures.
MONSANTO’S POSITION
Specifically, Monsanto has always asserted that the “defect” (the glyphosate ingredient) in its Roundup herbicide is actually not a defect because, as the company claims, glyphosate is not carcinogenic. As such, the defendants claim, the product cannot be the cause of the plaintiffs’ cancer.
POSITION OF IARC AND OTHER SCIENTIFIC BODIES
However, mounds of scientific research have proved Monsanto’s claims to be untrue.
- The World Health Organization’s International Agency for Research on Cancer (IARC) has remained committed to its position that glyphosate is “probably carcinogenic” to humans. The IARC arrived at this conclusion after reviewing over 1,000 research studies on the glyphosate-cancer connection.
- Further deepening the well of proof about glyphosate’s carcinogenic properties, the University of Washington conducted a meta-analysis of multiple studies on glyphosate and found that agricultural workers who were exposed to Roundup suffered a 41 percent greater risk of developing non-Hodgkin’s lymphoma than their counterparts who had been either infrequently or never exposed to the herbicide.
- According to a study published in the International Journal of Cancer, a person’s chance of developing NHL can double over only 10 days of Roundup exposure in a single year.
TYPES OF PEOPLE WHO HAVE FILED ROUNDUP CANCER LAWSUITS
People across a variety of jobs and careers who used Roundup in a broad range of settings for an equally diverse set of purposes have been filing lawsuits against Monsanto for their glyphosate-based cancer.
Among the jobs most commonly associated with Roundup-caused cancer are the jobs where workers are most heavily and frequently exposed to the chemical. For example:
- Military personnel
- Surveyors
- Commercial farmers
- Landscapers
- Soil scientists
- Groundskeepers
However, other parties might also be at risk. One of the first three Roundup product liability cases against Monsanto was filed—and eventually won—by a California homeowner who used the weed killer to maintain his personal, private lawn and garden.
CALL ZANES LAW TODAY FOR A FREE CASE REVIEW
If you were exposed to Roundup or another glyphosate-based herbicide and have since developed cancer, Zanes Law will do everything from A to Z to get you the compensation you deserve. If you want to file a Roundup weed killer cancer lawsuit, call us today at (833) 214-0917 for a free case review.